ACM Research, Inc. has completed an IPO and has been listed on NASDAQ
ACM Research, Inc.(ACM) has been listed on NASDAQ through an IPO to enhance its brand image, solidify IP protection and function as a global platform for future acquisitions.
ACM Research, Inc. develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. The company’s Ultra C equipment is designed to remove random defects from a wafer surface effectively, without damaging a wafer or its features, even at an increasingly advanced process node (the minimum line width on a chip) of 22 nanometers, or less. ACM’s equipment is based on its innovative proprietary Space Alternated Phase Shift (SAPS) and Timely Energized Bubble Oscillation (TEBO) technologies. ACM developed proprietary technologies to enable manufacturers to produce chips that reach their ultimate physical limitations while maintaining product yield, which is the percentage of chips on a wafer that meet manufacturing specifications. The company, founded in 1998 and headquartered in Fremont, California, markets and sells its products through direct sales force and third-party representatives.
Oaklins’ team in Shanghai assisted ACM's management team and shareholders through the whole process to the successful completion of an IPO and subsequent listing on NASDAQ.


Talk to the deal team
Related deals
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moredoValue has finalized a rights issue
doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.
Learn more